Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Wegner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|November 25, 2020
New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19 : In Responding to a Global Health Crisis, Industry is Discovering New, Efficient Ways of Meeting ObjectivesMax Wegner
Pulmonary Circulation|May 11, 2013
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committeeIan Adatia, Sheila G Haworth, Max Wegner, et al.
Drug Discovery Today|February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspectiveInkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
Biomedicines|January 21, 2023
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial FibrillationLeon Blöbaum, Marco Witkowski, Max Wegner, et al.
International Journal of Molecular Sciences|April 13, 2024
Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial FibrillationJulian Friebel, Max Wegner, Leon Blöbaum, et al.
Cells|January 8, 2023
Cytotoxic CD8<sup>+</sup> T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial FibrillationJulian Friebel, Marco Witkowski, Max Wegner, et al.
Nature Reviews. Drug Discovery|June 5, 2020
Cloud-based data systems in drug regulation: an industry perspectiveAndrew S Robertson, Hilary Malone, Fabio Bisordi, et al.
Clinical and Translational Science|April 9, 2022
A vision for integrated publicly available information on regulated medical productsKhyati Roberts, Roopal Thakkar, Lina Aljuburi, et al.
Clinical Pharmacology and Therapeutics|April 28, 2020
Creating E-Labeling Platforms: An Industry VisionKhyati Roberts, Roopal Thakkar, Deborah Autor, et al.
Clinical Pharmacology and Therapeutics|September 29, 2020
COVID-19: A Catalyst to Accelerate Global Regulatory TransformationJerry Stewart, Peter Honig, Lina AlJuburi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|November 25, 2020
New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19 : In Responding to a Global Health Crisis, Industry is Discovering New, Efficient Ways of Meeting ObjectivesMax Wegner
Pulmonary Circulation|May 11, 2013
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committeeIan Adatia, Sheila G Haworth, Max Wegner, et al.
Drug Discovery Today|February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspectiveInkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
Biomedicines|January 21, 2023
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial FibrillationLeon Blöbaum, Marco Witkowski, Max Wegner, et al.
International Journal of Molecular Sciences|April 13, 2024
Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial FibrillationJulian Friebel, Max Wegner, Leon Blöbaum, et al.
Cells|January 8, 2023
Cytotoxic CD8<sup>+</sup> T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial FibrillationJulian Friebel, Marco Witkowski, Max Wegner, et al.
Nature Reviews. Drug Discovery|June 5, 2020
Cloud-based data systems in drug regulation: an industry perspectiveAndrew S Robertson, Hilary Malone, Fabio Bisordi, et al.
Clinical and Translational Science|April 9, 2022
A vision for integrated publicly available information on regulated medical productsKhyati Roberts, Roopal Thakkar, Lina Aljuburi, et al.
Clinical Pharmacology and Therapeutics|April 28, 2020
Creating E-Labeling Platforms: An Industry VisionKhyati Roberts, Roopal Thakkar, Deborah Autor, et al.
Clinical Pharmacology and Therapeutics|September 29, 2020
COVID-19: A Catalyst to Accelerate Global Regulatory TransformationJerry Stewart, Peter Honig, Lina AlJuburi, et al.
Pageof 2